Sfoglia per Rivista CANCER
A nomogram predicting long-term biochemical recurrence after radical prostatectomy
2008-01-01 Suardi, N; Porter, Cr; Reuther, Am; Walz, Jc; Kodama, K; Gibbons, Rp; Correa, R; Montorsi, F; Graefen, M; Huland, H; Klein, Ea; Karakiewicz, Pi
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum
2015-01-01 Prat, Jaime; Odicino, Franco
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients
2012-01-01 Suardi, N; Gallina, A; Capitanio, U; Salonia, A; Lughezzani, G; Freschi, M; Mottrie, A; Rigatti, P; Montorsi, F; Briganti, A
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery
2018-01-01 Simonetti, Giorgia; Padella, Antonella; do Valle, Italo Farìa; Fontana, Maria Chiara; Fonzi, Eugenio; Bruno, Samantha; Baldazzi, Carmen; Guadagnuolo, Viviana; Manfrini, Marco; Ferrari, ERIKA ANNA; Paolini, Stefania; Papayannidis, Cristina; Marconi, Giovanni; Franchini, Eugenia; Zuffa, Elisa; Laginestra, Maria Antonella; Zanotti, Federica; Astolfi, Annalisa; Iacobucci, Ilaria; Bernardi, Simona; Sazzini, Marco; Ficarra, Elisa; Hernandez, Jesus Maria; Vandenberghe, Peter; Cools, Jan; Bullinger, Lars; Ottaviani, Emanuela; Testoni, Nicoletta; Cavo, Michele; Haferlach, Torsten; Castellani, Gastone; Remondini, Daniel; Martinelli, Giovanni
Circulating Estradiol, But Not Testosterone, Is a Significant Predictor of High-Grade Prostate Cancer in Patients Undergoing Radical Prostatectomy
2011-01-01 Salonia, A; Gallina, A; Briganti, A; Suardi, N; Capitanio, U; Abdollah, F; Bertini, R; Freschi, M; Rigatti, P; Montorsi, F
Circulating neuroendocrine markers in patients with prostate carcinoma.
2000-01-01 Berruti, Alfredo; Dogliotti, L; Mosca, A; Bellina, M; Mari, M; Torta, M; Tarabuzzi, R; Bollito, E; D., Fontana; Angeli, A.
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19
2020-01-01 Cattaneo, C.; Daffini, R.; Pagani, C.; Salvetti, M.; Mancini, V.; Borlenghi, E.; D'Adda, M.; Oberti, M.; Paini, A.; De Ciuceis, C.; Barbullushi, K.; Cancelli, V.; Belotti, A.; Re, A.; Motta, M.; Peli, A.; Bianchetti, N.; Anastasia, A.; Dalceggio, D.; Roccaro, A. M.; Tucci, A.; Cairoli, R.; Muiesan, M. L.; Rossi, G.
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse
2011-01-01 Tiribelli, M; Geromin, A; Michelutti, A; Cavallin, M; Pianta, A; Fabbro, D; Russo, Domenico; Damante, G; Fanin, R; Damiani, D.
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men
2008-01-01 Chun, Fkh; Haese, A; Ahyai, Sa; Walz, J; Suardi, N; Capitanio, U; Graefen, M; Erbersdobler, A; Huland, H; Karakiewicz, Pi
Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features
2008-01-01 Suardi, N; Capitanio, U; Chun, Fkh; Graefen, M; Perrotte, P; Schlomm, T; Haese, A; Huland, H; Erbersdobler, A; Montorsi, F; Karakiewicz, Pi
Drug resistance and BCR-ABL kinase domain mutations in philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement.
2014-01-01 Soverini, S; De Benedittis, C; Papayannidis, C; Paolini, S; Venturi, C; Iacobucci, I; Luppi, M; Bresciani, P; Salvucci, M; Russo, Domenico; Sica, S; Orlandi, E; Intermesoli, T; Gozzini, A; Bonifacio, M; Rigolin, Gm; Pane, F; Baccarani, M; Cavo, M; Martinelli, G.
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of (90) Y-DOTA-D-Phe1-Tyr3 octreotide.
2012-01-01 Savelli, G; Bertagna, Francesco; Franco, F; Dognini, L; Bosio, G; Migliorati, E; Rodella, C; Biasiotto, Giorgio; Bettinsoli, G; Minari, C; Zaniboni, A; Ferrari, C; Tomassetti, P; Ferrari, V; Giubbini, Raffaele
Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy
2010-01-01 Deganello, Alberto; A., Franchi; I., Sardi; L., Pignataro; Leemans, C. R.; O., Gallo
Histologic evaluation of necrosis in osteosarcoma indiced by chemioterapy.
1985-01-01 Picci, P; Bacci, G; Campanacci, M; Gasparini, M; Pilotti, S; Cerasoli, S; Bertoni, F; Guerra, A; Capanna, R; Albisinni, U; Galletti, S; Gherlinzoni, F; Calderoli, P; Sudanese, A; Baldini, N; Bernini, Marzia; Jaffe, N.
Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma
2001-01-01 Re, A; Casari, S; Cattaneo, C; Facchetti, F; Cadeo, G; Carosi, G; Rossi, G
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer
In corso di stampa Bellone, S; Anfossi, S; O'Brien, Tj; Cannon, Mj; Silasi, Da; Azodi, M; Schwartz, Pe; Rutherford, Tj; Pecorelli, Sergio; Santin, Ad
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis
2020-01-01 Palandri, F.; Breccia, M.; Bonifacio, M.; Polverelli, N.; Elli, E. M.; Benevolo, G.; Tiribelli, M.; Abruzzese, E.; Iurlo, A.; Heidel, F. H.; Bergamaschi, M.; Tieghi, A.; Crugnola, M.; Cavazzini, F.; Binotto, G.; Isidori, A.; Sgherza, N.; Bosi, C.; Martino, B.; Latagliata, R.; Auteri, G.; Scaffidi, L.; Griguolo, D.; Trawinska, M.; Cattaneo, D.; Catani, L.; Krampera, M.; Lemoli, R. M.; Cuneo, A.; Semenzato, G.; Foa, R.; Di Raimondo, F.; Bartoletti, D.; Cavo, M.; Palumbo, G. A.; Vianelli, N.
Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-Oncologico del Nord Est (Northeast Uro-Oncological Group) Penile Cancer data base data.
2005-01-01 Ficarra, V; Zattoni, F; COSCIANI CUNICO, Sergio; Galetti, Tp; Luciani, L; Fandella, A; Guazzieri, S; Maruzzi, D; Sava, T; Siracusano, S; Pilloni, S; Tasca, A; Martignoni, G; Gardiman, M; Tardanico, R; Zambolin, T; Cisternino, A; Artibani, W; GRUPPO URO ONCOLOGICO DEL NORD EST NORTHEAST URO ONCOLOGICAL GROUP PENILE CANCER, Project
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020-01-01 Elad, S.; Cheng, K. K. F.; Lalla, R. V.; Yarom, N.; Hong, C.; Logan, R. M.; Bowen, J.; Gibson, R.; Saunders, D. P.; Zadik, Y.; Ariyawardana, A.; Correa, M. E.; Ranna, V.; Bossi, P.; Arany, P.; Al-Azri, A. R.; Blijlevens, N.; Hovan, A.; Fregnani, E.; Fulton, J.; Gueiros, L. A.; Rouleau, T.; Coller, J. K.; Al-Dasooqi, N.; Wardill, H.; Ameringer, S.; Antunes, H. S.; Bateman, E. H.; Bektas, K.; Bensadoun, R. -J.; Ten Bohmer, K.; Brito-Dellan, N.; Castillo, D.; Chiang, K.; de Mooij, C.; Eilers, J.; Epstein, J.; Galiti, D.; Fall-Dickson, J. M.; Gobbo, M.; Issa Hazboun, H.; Jensen, S. B.; Johansen, J.; Joy, J.; Joy, K.; Kandwal, A.; Kataoka, T.; Keefe, D.; Loprinzi, C. L.; Lubart, R.; Skripnik Lucas, A.; Majorana, A.; Mayo, B.; de Mooij, C.; Mori, T.; Nair, R. G.; Nasr, N.; Nicolatou-Galitis, O.; Ottaviani, G.; Migliorati, C.; Pentenero, M.; Porcello, L.; Peterson, D.; Potting, C.; Raber-Durlacher, J.; van Sebille, Y. Z. A.; Soga, Y.; Sonis, S.; Stringer, A. M.; Thorpe, D.; Tilly, V.; Tissing, W.; Toro, J. J.; Treister, N. S.; Vaddi, A.; Weikel, D.; van de Wetering, M.; Zur, E.
Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
1998-01-01 Berruti, Alfredo; M., Terzolo; A., Pia; A., Angeli; L., Dogliotti
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A nomogram predicting long-term biochemical recurrence after radical prostatectomy | 1-gen-2008 | Suardi, N; Porter, Cr; Reuther, Am; Walz, Jc; Kodama, K; Gibbons, Rp; Correa, R; Montorsi, F; Graefen, M; Huland, H; Klein, Ea; Karakiewicz, Pi | |
| Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum | 1-gen-2015 | Prat, Jaime; Odicino, Franco | |
| Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients | 1-gen-2012 | Suardi, N; Gallina, A; Capitanio, U; Salonia, A; Lughezzani, G; Freschi, M; Mottrie, A; Rigatti, P; Montorsi, F; Briganti, A | |
| Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery | 1-gen-2018 | Simonetti, Giorgia; Padella, Antonella; do Valle, Italo Farìa; Fontana, Maria Chiara; Fonzi, Eugenio; Bruno, Samantha; Baldazzi, Carmen; Guadagnuolo, Viviana; Manfrini, Marco; Ferrari, ERIKA ANNA; Paolini, Stefania; Papayannidis, Cristina; Marconi, Giovanni; Franchini, Eugenia; Zuffa, Elisa; Laginestra, Maria Antonella; Zanotti, Federica; Astolfi, Annalisa; Iacobucci, Ilaria; Bernardi, Simona; Sazzini, Marco; Ficarra, Elisa; Hernandez, Jesus Maria; Vandenberghe, Peter; Cools, Jan; Bullinger, Lars; Ottaviani, Emanuela; Testoni, Nicoletta; Cavo, Michele; Haferlach, Torsten; Castellani, Gastone; Remondini, Daniel; Martinelli, Giovanni | |
| Circulating Estradiol, But Not Testosterone, Is a Significant Predictor of High-Grade Prostate Cancer in Patients Undergoing Radical Prostatectomy | 1-gen-2011 | Salonia, A; Gallina, A; Briganti, A; Suardi, N; Capitanio, U; Abdollah, F; Bertini, R; Freschi, M; Rigatti, P; Montorsi, F | |
| Circulating neuroendocrine markers in patients with prostate carcinoma. | 1-gen-2000 | Berruti, Alfredo; Dogliotti, L; Mosca, A; Bellina, M; Mari, M; Torta, M; Tarabuzzi, R; Bollito, E; D., Fontana; Angeli, A. | |
| Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19 | 1-gen-2020 | Cattaneo, C.; Daffini, R.; Pagani, C.; Salvetti, M.; Mancini, V.; Borlenghi, E.; D'Adda, M.; Oberti, M.; Paini, A.; De Ciuceis, C.; Barbullushi, K.; Cancelli, V.; Belotti, A.; Re, A.; Motta, M.; Peli, A.; Bianchetti, N.; Anastasia, A.; Dalceggio, D.; Roccaro, A. M.; Tucci, A.; Cairoli, R.; Muiesan, M. L.; Rossi, G. | |
| Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse | 1-gen-2011 | Tiribelli, M; Geromin, A; Michelutti, A; Cavallin, M; Pianta, A; Fabbro, D; Russo, Domenico; Damante, G; Fanin, R; Damiani, D. | |
| Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men | 1-gen-2008 | Chun, Fkh; Haese, A; Ahyai, Sa; Walz, J; Suardi, N; Capitanio, U; Graefen, M; Erbersdobler, A; Huland, H; Karakiewicz, Pi | |
| Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features | 1-gen-2008 | Suardi, N; Capitanio, U; Chun, Fkh; Graefen, M; Perrotte, P; Schlomm, T; Haese, A; Huland, H; Erbersdobler, A; Montorsi, F; Karakiewicz, Pi | |
| Drug resistance and BCR-ABL kinase domain mutations in philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement. | 1-gen-2014 | Soverini, S; De Benedittis, C; Papayannidis, C; Paolini, S; Venturi, C; Iacobucci, I; Luppi, M; Bresciani, P; Salvucci, M; Russo, Domenico; Sica, S; Orlandi, E; Intermesoli, T; Gozzini, A; Bonifacio, M; Rigolin, Gm; Pane, F; Baccarani, M; Cavo, M; Martinelli, G. | |
| Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of (90) Y-DOTA-D-Phe1-Tyr3 octreotide. | 1-gen-2012 | Savelli, G; Bertagna, Francesco; Franco, F; Dognini, L; Bosio, G; Migliorati, E; Rodella, C; Biasiotto, Giorgio; Bettinsoli, G; Minari, C; Zaniboni, A; Ferrari, C; Tomassetti, P; Ferrari, V; Giubbini, Raffaele | |
| Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy | 1-gen-2010 | Deganello, Alberto; A., Franchi; I., Sardi; L., Pignataro; Leemans, C. R.; O., Gallo | |
| Histologic evaluation of necrosis in osteosarcoma indiced by chemioterapy. | 1-gen-1985 | Picci, P; Bacci, G; Campanacci, M; Gasparini, M; Pilotti, S; Cerasoli, S; Bertoni, F; Guerra, A; Capanna, R; Albisinni, U; Galletti, S; Gherlinzoni, F; Calderoli, P; Sudanese, A; Baldini, N; Bernini, Marzia; Jaffe, N. | |
| Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma | 1-gen-2001 | Re, A; Casari, S; Cattaneo, C; Facchetti, F; Cadeo, G; Carosi, G; Rossi, G | |
| Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer | In corso di stampa | Bellone, S; Anfossi, S; O'Brien, Tj; Cannon, Mj; Silasi, Da; Azodi, M; Schwartz, Pe; Rutherford, Tj; Pecorelli, Sergio; Santin, Ad | |
| Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis | 1-gen-2020 | Palandri, F.; Breccia, M.; Bonifacio, M.; Polverelli, N.; Elli, E. M.; Benevolo, G.; Tiribelli, M.; Abruzzese, E.; Iurlo, A.; Heidel, F. H.; Bergamaschi, M.; Tieghi, A.; Crugnola, M.; Cavazzini, F.; Binotto, G.; Isidori, A.; Sgherza, N.; Bosi, C.; Martino, B.; Latagliata, R.; Auteri, G.; Scaffidi, L.; Griguolo, D.; Trawinska, M.; Cattaneo, D.; Catani, L.; Krampera, M.; Lemoli, R. M.; Cuneo, A.; Semenzato, G.; Foa, R.; Di Raimondo, F.; Bartoletti, D.; Cavo, M.; Palumbo, G. A.; Vianelli, N. | |
| Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-Oncologico del Nord Est (Northeast Uro-Oncological Group) Penile Cancer data base data. | 1-gen-2005 | Ficarra, V; Zattoni, F; COSCIANI CUNICO, Sergio; Galetti, Tp; Luciani, L; Fandella, A; Guazzieri, S; Maruzzi, D; Sava, T; Siracusano, S; Pilloni, S; Tasca, A; Martignoni, G; Gardiman, M; Tardanico, R; Zambolin, T; Cisternino, A; Artibani, W; GRUPPO URO ONCOLOGICO DEL NORD EST NORTHEAST URO ONCOLOGICAL GROUP PENILE CANCER, Project | |
| MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy | 1-gen-2020 | Elad, S.; Cheng, K. K. F.; Lalla, R. V.; Yarom, N.; Hong, C.; Logan, R. M.; Bowen, J.; Gibson, R.; Saunders, D. P.; Zadik, Y.; Ariyawardana, A.; Correa, M. E.; Ranna, V.; Bossi, P.; Arany, P.; Al-Azri, A. R.; Blijlevens, N.; Hovan, A.; Fregnani, E.; Fulton, J.; Gueiros, L. A.; Rouleau, T.; Coller, J. K.; Al-Dasooqi, N.; Wardill, H.; Ameringer, S.; Antunes, H. S.; Bateman, E. H.; Bektas, K.; Bensadoun, R. -J.; Ten Bohmer, K.; Brito-Dellan, N.; Castillo, D.; Chiang, K.; de Mooij, C.; Eilers, J.; Epstein, J.; Galiti, D.; Fall-Dickson, J. M.; Gobbo, M.; Issa Hazboun, H.; Jensen, S. B.; Johansen, J.; Joy, J.; Joy, K.; Kandwal, A.; Kataoka, T.; Keefe, D.; Loprinzi, C. L.; Lubart, R.; Skripnik Lucas, A.; Majorana, A.; Mayo, B.; de Mooij, C.; Mori, T.; Nair, R. G.; Nasr, N.; Nicolatou-Galitis, O.; Ottaviani, G.; Migliorati, C.; Pentenero, M.; Porcello, L.; Peterson, D.; Potting, C.; Raber-Durlacher, J.; van Sebille, Y. Z. A.; Soga, Y.; Sonis, S.; Stringer, A. M.; Thorpe, D.; Tilly, V.; Tissing, W.; Toro, J. J.; Treister, N. S.; Vaddi, A.; Weikel, D.; van de Wetering, M.; Zur, E. | |
| Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer. | 1-gen-1998 | Berruti, Alfredo; M., Terzolo; A., Pia; A., Angeli; L., Dogliotti |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile